Connect Sign In
Discover how ARUP is advancing laboratory medicine at ADLM 2026 through research presentations, expert insights, and innovative diagnostic solutions.
ARUP has published the Summer 2026 edition of Magnify, which highlights applied AI in lab medicine, patient impact, and strategies to help health systems and labs thrive.
The study, published in the Journal of Clinical Microbiology, highlights the increased sensitivity and advantages of AI-based screening compared with manual microscopy.
Benjamin Bradley, MD, PhD, discusses the current risk of Andes hantavirus and Ebola Bundibugyo in the U.S., ARUP’s response, and testing recommendations.
An inside look at three ARUP labs—Mass Spec 1, Exception Handling, and Immunohistochemistry—showing how teamwork, innovation, and behind-the-scenes dedication support accurate testing and care.
Healthcare Advisory Services Vice President Sandy Richman will present strategies for hospital laboratories to launch or grow successful outreach programs and become strategic health system partners.
During Cervical Cancer Awareness Month, ARUP Consult® highlights self-collected vaginal specimen testing as an FDA-approved, guideline-supported option to help address HPV screening barriers.
ARUP Laboratories’ dual-target molecular measles virus assay provides a highly sensitive, specific, and rapid assay to aid the public health response to ongoing measles outbreaks.
RIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders
Tracy George, MD, ARUP chief scientific officer and Innovation Business Unit president, will help advance life sciences innovation and strengthen Utah’s healthcare ecosystem with BioUtah.
Deploying artificial intelligence (AI) solutions in the lab brings several challenges. In this white paper, ARUP experts offer actionable advice for determining whether AI is right for your lab.
At upcoming conferences, ARUP experts will highlight a new blood-based biomarker assay for Alzheimer’s disease and share a presentation on building a successful laboratory outreach program.
